The 'Omics' of Amyotrophic Lateral Sclerosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Trends in Molecular Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2015.11.001PMID 26691296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The modulation of two motor behaviors by persistent sodium currents in Xenopus laevis tadpoles

  2017cited by this paper
• Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review

  2017cited by this paper
• Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis

  2016cited by this paper
• Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis

  2015cited by this paper
• Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features.

  2015cited by this paper
• U1 snRNP is mislocalized in ALS patient fibroblasts bearing NLS mutations in FUS and is required for motor neuron outgrowth in zebrafish

  2015cited by this paper
• Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers

  2015cited by this paper
• Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translation.

  2015cited by this paper
• A fruitful endeavor: modeling ALS in the fruit fly.

  2015cited by this paper
• Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis.

  2015cited by this paper
• Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport.

  2015cited by this paper
• C9ORF72 hexanucleotide repeat expansions are a frequent cause of Huntington disease phenocopies in the Greek population.

  2015cited by this paper
• Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

  2015cited by this paper
• Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics

  2014cited by this paper
• Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease

  2014cited by this paper
• miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients

  2014cited by this paper
• Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients.

  2014cited by this paper
• An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA–FUS regulatory circuitry

  2014cited by this paper
• Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis.

  2014cited by this paper
• C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins

  2014cited by this paper
• The RNA-binding Protein TDP-43 Selectively Disrupts MicroRNA-1/206 Incorporation into the RNA-induced Silencing Complex*♦

  2014cited by this paper
• The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients

  2014cited by this paper
• Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells

  2014cited by this paper
• hnRNPA2B1 and hnRNPA1 mutations are rare in patients with "multisystem proteinopathy" and frontotemporal lobar degeneration phenotypes.

  2014cited by this paper
• Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers.

  2014cited by this paper
• Human SOD1-G93A specific distribution evidenced in murine brain of a transgenic model for amyotrophic lateral sclerosis by MALDI imaging mass spectrometry.

  2014cited by this paper
• A Novel Acylaminoimidazole Derivative, WN1316, Alleviates Disease Progression via Suppression of Glial Inflammation in ALS Mouse Model

  2014cited by this paper
• Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding

  2014cited by this paper
• Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis

  2014cited by this paper
• Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis

  2014cited by this paper
• Fishing for causes and cures of motor neuron disorders

  2014cited by this paper
• Gene expression profile of SOD1-G93A mouse spinal cord, blood and muscle

  2013cited by this paper
• RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.

  2013cited by this paper
• Meta-analysis of gene expression profiling in amyotrophic lateral sclerosis: A comparison between transgenic mouse models and human patients

  2013cited by this paper
• ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis.

  2013cited by this paper
• Impact of the C9Orf72 expansion on brain glucose metabolism in ALS patients

  2013cited by this paper
• The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS

  2013cited by this paper
• Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS

  2013cited by this paper
• Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis.

  2013cited by this paper
• Relationship between cervical cord 1H‐magnetic resonance spectroscopy and clinoco‐electromyographic profile in amyotrophic lateral sclerosis

  2013cited by this paper
• Diffusion tensor imaging of the mouse brainstem and cervical spinal cord

  2013cited by this paper
• Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS

  2013cited by this paper
• Brain iron MRI: A biomarker for amyotrophic lateral sclerosis

  2013cited by this paper
• Investigating cell death mechanisms in amyotrophic lateral sclerosis using transcriptomics

  2013cited by this paper
• Targeting of Monomer/Misfolded SOD1 as a Therapeutic Strategy for Amyotrophic Lateral Sclerosis

  2012cited by this paper
• CSF markers in amyotrophic lateral sclerosis

  2012cited by this paper
• ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations.

  2012cited by this paper
• Evidence for an oligogenic basis of amyotrophic lateral sclerosis.

  2012cited by this paper
• Amyotrophic lateral sclerosis.

  2012cited by this paper
• Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS

  2012cited by this paper
• Aberrant Localization of FUS and TDP43 Is Associated with Misfolding of SOD1 in Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Intravenous Mesenchymal Stem Cells Improve Survival and Motor Function in Experimental Amyotrophic Lateral Sclerosis

  2012cited by this paper
• TDP-43 Identified from a Genome Wide RNAi Screen for SOD1 Regulators

  2012cited by this paper
• Identification of Epigenetically Altered Genes in Sporadic Amyotrophic Lateral Sclerosis

  2012cited by this paper
• Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin

  2012cited by this paper
• Biochemical alterations associated with ALS

  2012cited by this paper
• A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis.

  2012cited by this paper
• Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis

  2012cited by this paper
• FUS stimulates microRNA biogenesis by facilitating co‐transcriptional Drosha recruitment

  2012cited by this paper
• Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

  2012cited by this paper
• Five years of GWAS discovery.

  2012cited by this paper
• Misregulated RNA processing in amyotrophic lateral sclerosis.

  2012cited by this paper
• Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.

  2012cited by this paper
• Glycans in Sera of Amyotrophic Lateral Sclerosis Patients and Their Role in Killing Neuronal Cells

  2012cited by this paper
• Intracerebroventricular Injection of Encapsulated Human Mesenchymal Cells Producing Glucagon-Like Peptide 1 Prolongs Survival in a Mouse Model of ALS

  2012cited by this paper
• Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis

  2012cited by this paper
• Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.

  2012cited by this paper
• TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes

  2012cited by this paper
• Serum N-acetylaspartate level in amyotrophic lateral sclerosis.

  2011cited by this paper
• The “Dying-Back” Phenomenon of Motor Neurons in ALS

  2011cited by this paper
• FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis

  2011cited by this paper
• A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

  2011cited by this paper
• Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS

  2011cited by this paper
• Astrocytes from Familial and Sporadic ALS Patients are Toxic to Motor Neurons

  2011cited by this paper
• Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS

  2011cited by this paper
• Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia

  2011cited by this paper
• Apoptosis‐Inducing Factor and Cyclophilin A Cotranslocate to the Motor Neuronal Nuclei in Amyotrophic Lateral Sclerosis Model Mice

  2011cited by this paper
• An exploratory study of serum urate levels in patients with amyotrophic lateral sclerosis

  2011cited by this paper
• Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells

  2011cited by this paper
• Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.

  2011cited by this paper
• Copy number imbalances in blood and hair in monozygotic twins discordant for amyotrophic lateral sclerosis.

  2011cited by this paper
• Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation

  2011cited by this paper
• Looking for differences in copy number between blood and brain in sporadic amyotrophic lateral sclerosis

  2011cited by this paper
• A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.

  2011cited by this paper
• FTD and ALS: genetic ties that bind.

  2011cited by this paper
• Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis

  2011cited by this paper
• Conditioned media from cell lines: A complementary model to clinical specimens for the discovery of disease‐specific biomarkers

  2011cited by this paper
• TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy

  2010cited by this paper
• A large genome scan for rare CNVs in amyotrophic lateral sclerosis.

  2010cited by this paper
• An estimate of amyotrophic lateral sclerosis heritability using twin data

  2010cited by this paper
• TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.

  2010cited by this paper
• Mutations of optineurin in amyotrophic lateral sclerosis

  2010cited by this paper
• Riluzole, neuroprotection and amyotrophic lateral sclerosis.

  2010cited by this paper
• Nuclear factor TDP‐43 can affect selected microRNA levels

  2010cited by this paper
• 1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis

  2010cited by this paper
• Advances in the application of MRI to amyotrophic lateral sclerosis.

  2010cited by this paper
• Induction of Protective Immunity by Vaccination With Wild-Type Apo Superoxide Dismutase 1 in Mutant SOD1 Transgenic Mice

  2010cited by this paper
• The Association of Exposure to Lead, Mercury, and Selenium and the Development of Amyotrophic Lateral Sclerosis and the Epigenetic Implications

  2010cited by this paper
• Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis.

  2010cited by this paper
• Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach.

  2010cited by this paper

• VEGF expression disparities in brainstem motor neurons of the SOD1G93A ALS model: Correlations with neuronal vulnerability

  2024cites this paper
• Unraveling the Epigenetic Landscape: Insights into Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis

  2024cites this paper
• MAPK/MAK/MRK overlapping kinase (MOK) controls microglial inflammatory/type-I IFN responses via Brd4 and is involved in ALS

  2023cites this paper
• The implications of DNA methylation for amyotrophic lateral sclerosis.

  2023cites this paper
• Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis

  2023cites this paper
• Mendelian Randomization Identifies Genetically Supported Drug Targets for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

  2023cites this paper
• Systems Biology to Address Unmet Medical Needs in Neurological Disorders.

  2022cites this paper
• Integrated network pharmacology approach shows a potential role of Ginseng catechins and ginsenosides in modulating protein aggregation in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Esclerosis lateral amiotrófica y dermatoglifia. Revisión sistemática

  2022cites this paper
• Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis

  2022cites this paper
• Occupation and amyotrophic lateral sclerosis risk: a case-control study in the isolated island population of Malta

  2021cites this paper
• Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)

  2021cites this paper
• Distinct responses of human peripheral blood cells to different misfolded protein oligomers

  2021cites this paper
• MicroRNA expression in animal models of amyotrophic lateral sclerosis and potential therapeutic approaches

  2021cites this paper
• AUTOLOGOUS STEM CELL TRANSPLANTATION AND IMMUNOMODULATION IN AMYOTROPHIC LATERAL SCLEROSIS

  2021cites this paper
• OMICS-BASED EXPLORATION AND FUNCTIONAL VALIDATION OF NEUROTROPHIC FACTORS AND HISTAMINE AS THERAPEUTIC TARGETS IN ALS.

  2020cites this paper
• Early alterations of RNA metabolism and splicing from adult corticospinal neurons in an ALS mouse model

  2019cites this paper
• Unique characteristics of the genetics epidemiology of amyotrophic lateral sclerosis in China

  2019cites this paper
• FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice

  2019cites this paper
• Neuroimaging and clinical trials with stem cells in amyotrophic lateral sclerosis: Present and future perspectives

  2019cites this paper
• Neuroimaging and clinical trials with stem cells in amyotrophic lateral sclerosis: present and future perspectives.

  2019cites this paper
• Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration.

  2019cites this paper
• Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates.

  2019cites this paper
• Systems Biology of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis

  2018cites this paper
• Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis

  2018cites this paper
• TDP-43 post-translational modifications in health and disease

  2018cites this paper
• Metabolic Reprogramming in Amyotrophic Lateral Sclerosis

  2018cites this paper
• The modulation of two motor behaviors by persistent sodium currents in Xenopus laevis tadpoles

  2017cites this paper
• A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A‐SOD1 mouse model of amyotrophic lateral sclerosis

  2017cites this paper
• Control of Movement The modulation of two motor behaviors by persistent sodium currents in Xenopus laevis tadpoles

  2017cites this paper
• Epigenetic Mechanisms of Gene Regulation in Amyotrophic Lateral Sclerosis.

  2017cites this paper
• Analysis of SOD1 mutations in a Chinese population with amyotrophic lateral sclerosis: a case-control study and literature review

  2017cites this paper
• Proteomic profiling of muscle fibre type shifting in neuromuscular diseases

  2016cites this paper
• Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis

  2016cites this paper
• Protein folding alterations in amyotrophic lateral sclerosis.

  2016cites this paper
• Further development of biomarkers in amyotrophic lateral sclerosis

  2016cites this paper